GTS Securities’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-36,700
Closed -$103K – 1782
2024
Q3
$103K Sell
36,700
-20,700
-36% -$47.4K ﹤0.01% 3796
2024
Q2
$70.6K Buy
57,400
+8,400
+17% +$7.54K ﹤0.01% 3676
2024
Q1
$38.9K Buy
49,000
+17,900
+58% +$16.3K ﹤0.01% 3655
2023
Q4
$29.6K Sell
31,100
-3,900
-11% -$3.83K ﹤0.01% 3882
2023
Q3
$37.8K Buy
+35,000
New +$41.6K ﹤0.01% 3744

Other funds holding CLOV

GTS Securities's CLOV Position: Q2 2026 in Review

GTS Securities opened a new position in Clover Health Investments (CLOV) in Q2 2026: 13,664 shares worth $71.6K. The stake represents ﹤0.01% of the portfolio and ranks #1269 among its holdings. This is a return to the name: GTS Securities previously reported a position in CLOV as recently as Q4 2025.

GTS Securities first reported a position in CLOV in Q1 2024 and has held it in 4 quarters since. The position peaked at $89.8K in Q2 2024. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • GTS Securities held 13,664 shares of Clover Health Investments worth $71.6K as of Q2 2026.
  • Clover Health Investments was a new GTS Securities position in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1269 holding.
  • GTS Securities first reported a position in Clover Health Investments in Q1 2024 and has held it in 4 quarters since.
  • GTS Securities's Clover Health Investments position peaked at $89.8K in Q2 2024.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.